Importantly, neither engineered chemerin expression nor incubation of mouse B16F0 melanoma cells with exogenous, recombinant chemerin affected in vitro growth or phenotype, suggesting chemerin's main anti-tumor activity was due primarily to its ability to recruit immune effector cells into the TME. The gene discussed is RARRES2; the disease is melanoma.